MedTrace Logo

Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education

NCT05761782 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-05-09

No results posted yet for this study

Summary

The University of California Davis, Comprehensive Cancer Center's (UCDCCC) Office of Community Outreach and Engagement (OCOE) serves the 19 catchment counties which approximately consists of 5 million residents. Currently, the overall catchment population cancer screening rates fall below 80%. The aim of OCOE is to increase cancer education (prevention, screening, and vaccination) and training. Through education, and encouraging participation in routine screening for early detection, this can help increase cancer knowledge. In addition to cancer education, OCOE wants to educate community members regarding modifiable risk factors which include tobacco usage, being overweight/obese (physical inactivity/poor nutrition), and lack of immunizations. By increasing knowledge of cancer prevention, screening, and vaccination this will help community members become more aware of their cancer risk.

Conditions

  • Cancer Awareness and Prevention Education

Interventions

BEHAVIORAL

Education

To educate catchment area residents on modifiable risk factors for cancer (e.g., screening, behavior, vaccination) and the importance of participation in cancer research. Provide participants with educational materials on cancer prevention, screening, and vaccination.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Julie Dang, Ph.D. · University of California, Davis

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-07
Primary Completion
2025-03-07
Completion
2025-03-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05761782 on ClinicalTrials.gov